Form D · Biotechnology
Veronica Holdings, LLC
New York, NY · CIK 0002028496
Offering snapshot reported Mar 3, 2025 · SEC filing
- Reported sold
- $142M Offering amount: $142M
- Investors reported
- 72 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2025 | Initial | $142,311,559 | No comparison | 72 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-539693
Source: Form D, filed Mar 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Army | Director |
| Konstantin Poukalov | Director |
| Anthony Storino | Director |
| Carlos Vazquez | Director |
| Edan Yacobovsky | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Slr Capital Partners 500 Park Avenue, 3rd Floor
New York, NY, 10022
New York, NY, 10022